Juan A. Marín-Jiménez,Anna Capasso,Matthew S. Lewis,Stacey M. Bagby,Sarah J. Hartman,Jeremy Shulman,Natalie M. Navarro,Hui Yu,Chris J. Rivard,Xiaoguang Wang,Jessica C. Barkow,Degui Geng,Adwitiya Kar,Ashley Yingst,Dejene M. Tufa,James T. Dolan,Patrick J. Blatchford,Brian M. Freed,Raul M. Torres,Eduardo Davila,Jill E. Slansky,Roberta Pelanda,S. Gail Eckhardt,Wells A. Messersmith,Jennifer R. Diamond,Christopher H. Lieu,Michael R. Verneris,Jing H. Wang,Katja Kiseljak-Vassiliades,Todd M. Pitts,Julie Lang

Abstract:Over the past decade, immunotherapies have revolutionized the treatment of cancer. Although the success of immunotherapy is remarkable, it is still limited to a subset of patients. More than 1500 clinical trials are currently ongoing with a goal of improving the efficacy of immunotherapy through co-administration of other agents. Preclinical, small-animal models are strongly desired to increase the pace of scientific discovery, while reducing the cost of combination drug testing in humans. Human immune system (HIS) mice are highly immune-deficient mouse recipients rtpeconstituted with human hematopoietic stem cells. These HIS-mice are capable of growing human tumor cell lines and patient-derived tumor xenografts. This model allows rapid testing of multiple, immune-related therapeutics for tumors originating from unique clinical samples. Using a cord blood-derived HIS-BALB/c-Rag2 null Il2rγ null SIRPα NOD (BRGS) mouse model, we summarize our experiments testing immune checkpoint blockade combinations in these mice bearing a variety of human tumors, including breast, colorectal, pancreatic, lung, adrenocortical, melanoma and hematological malignancies. We present in-depth characterization of the kinetics and subsets of the HIS in lymph and non-lymph organs and relate these to protocol development and immune-related treatment responses. Furthermore, we compare the phenotype of the HIS in lymph tissues and tumors. We show that the immunotype and amount of tumor infiltrating leukocytes are widely-variable and that this phenotype is tumor-dependent in the HIS-BRGS model. We further present flow cytometric analyses of immune cell subsets, activation state, cytokine production and inhibitory receptor expression in peripheral lymph organs and tumors. We show that responding tumors bear human infiltrating T cells with a more inflammatory signature compared to non-responding tumors, similar to reports of “responding” patients in human immunotherapy clinical trials. Collectively these data support the use of HIS mice as a preclinical model to test combination immunotherapies for human cancers, if careful attention is taken to both protocol details and data analysis.

Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice.

Follicular helper- and peripheral helper-like T cells drive autoimmune disease in human immune system mice

Humanized Mice Reveal New Insights into the Thymic Selection of Human Autoreactive CD8+ T Cells

Human Natural Regulatory T Cell Development, Suppressive Function, and Postthymic Maturation in a Humanized Mouse Model

T-cell development and activation in humanized mice lacking mouse major histocompatibility complexes

Long-Term Human Immune Reconstitution, T-Cell Development, and Immune Reactivity in Mice Lacking the Murine Major Histocompatibility Complex: Validation with Cellular and Gene Expression Profiles

Spontaneous human CD8 T cell and autoimmune encephalomyelitis-induced CD4/CD8 T cell lesions in the brain and spinal cord of HLA-DRB1*15-positive multiple sclerosis humanized immune system mice

A spontaneous model for autoimmune myocarditis using the human MHC molecule HLA-DQ8

Spontaneous human CD8 T cell and EAE-inducible human CD4/CD8 T cell lesions in the brain and spinal cord of HLA-DRB1*15-positive multiple sclerosis PBMC humanized mice

Failure of thymic deletion and instability of autoreactive Tregs drive autoimmunity in immune-privileged liver

Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis

Lymphotoxin Beta Receptor is Required for the Migration and Selection of Autoreactive T Cells in Thymic Medulla

Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes

Long-term Survival and Differentiation of Human Thymocytes in Human Thymus-Grafted Immunodeficient Mice

Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies

De novo construction of T cell compartment in humanized mice engrafted with iPSC-derived thymus organoids

Humanized Mice Reveal an Essential Role for Human Hepatocytes in the Development of the Liver Immune System.

MHC class II regulation of CD8+T cell tolerance and implications in autoimmunity and cancer immunotherapy

Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein

Induction of Haploidentical Mixed Chimerism Cures Autoimmune Type 1 Diabetes

Antigen-specific Human T-cell Responses and T Cell–dependent Production of Human Antibodies in a Humanized Mouse Model